Kimia Farma Apotek Named Sector Champion in the Retail Category
Through this achievement, Kimia Farma Group reaffirms its commitment ...
read more
Kimia Farma Secures Sublicense for Influenza Antiviral Drug (Baloxavir)
The Company's involvement in this global initiative is part of ...
read more
Kimia Farma Commitment to National Health Resilience
Kimia Farma introduces StemXera, a regenerative medicine innovation of stem cells and secretomes. ...
read more
Developing Medicine Ecosystem Through Education and Collaboration
This commitment is demonstrated through participation in ARUNA 2026, which brings together doctors. ...
read more
Strengthening StemXera's Market Penetration
Collaboration with RSCM and various healthcare institutions to develop regenerative medicine. ...
read more
Q2 2026 Operating Profit Rises Percent, National Health Prioritized
KAEF Strengthens Execution of National Health Priority Agenda ...
read more
KAEF Supports the 2030 TB Elimination Target
Commitment to TB elimination is demonstrated by its portfolio of TB control drug variants. ...
read more
Potential of IDR 700 Trillion, KAEF Builds an Integrated Healthy Aging Ecosystem
To bring health services closer to the community, Kimia Farma Group is positioning itself ...
read more
KFD Strengthens Commitment to National Health Program
Through strategic collaboration with the Faculty of Medicine, University of Indonesia (FKUI) ...
read more
Bio Farma Group Strengthens Health Diplomacy
The synergy between Bio Farma Group and the Ministry of Foreign Affairs is an important step ...
read more
Stemxera Launches, Expands Biotechnology and Global Collaboration
The Company Strengthens Its Product and Service Portfolio in the Biotechnology Sector ...
read more
BPOM RI's Support to Continue Supporting National Health Security
To increase support and close collaboration between BPOM and Kimia Farma ...
read more